Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
The Fine Blueprint of Integrating Immunotherapy and Radiotherapy
Details
This book provides a comprehensive overview of the principles and applications of immunotherapy and radiotherapy in the treatment of cancer. It covers the basic concepts of immunotherapy, immunology, radiation physics, radiobiology, and tumor biology, as well as their clinical aspects, such as patient selection, treatment planning, delivery techniques, toxicity management, outcome evaluation, and neoadjuvant approaches. The book also discusses the current challenges and future directions in the field, such as combining immunotherapy and radiotherapy, optimizing the timing and sequencing of treatments, developing novel biomarkers and predictive models, and implementing personalized and adaptive approaches. The book is intended for oncologists, radiation oncologists, medical physicists, radiation therapists, immunologists, researchers, students, and anyone interested in learning more about this rapidly evolving area of cancer therapy.
It concentrates on the intersection of immunotherapy and radiotherapy, two burgeoning fields in cancer treatment Explores the application of artificial intelligence, within the realms of cancer immunotherapy and radiotherapy Spotlights recent advancements and discoveries in neoadjuvant immunotherapy and neoadjuvant radiotherapy
Autorentext
Lin-Lin Bu is an associate professor and associate chief physician of Wuhan University Stomatological Hospital. He obtained his doctoral degrees at Wuhan University Stomatological Hospital, under the mentorship of professors Wen-Feng Zhang and Zhi-Jun Sun. He later conducted postdoctoral research with professor Zhen Gu s team at the University of North Carolina at Chapel Hill and the University of California, Los Angeles. He was selected as a young medical backbone talent in Wuhan and a top young medical talent (first level) in Hubei Province. Dr. Bu has received the Qiu Weiliu Oral and Maxillofacial Surgery Hope Award and the Zhu Yubi Medical Award from Wuhan University. His research focuses on oral and maxillofacial tumor resection and reconstruction (where he introduced the Less Is More concept); oral cancer lymph node metastasis (where he proposed the PUMP+ principle); the development of biomimetic drug delivery platforms combining medicine and engineering; and innovative teaching methods in head and neck surgery (where he proposed the PRI-E teaching model). He has authored 66 first- and corresponding-author papers in prestigious SCI journals. Dr. Bu has also been invited to serve as a guest editor for Seminars in Cancer Biology, Burns and Traum, Journal of Nanobiotechnology and BMC Medical Education.
Qiuji Wu obtained his Ph.D. degree in Oncology from Gustave Roussy Cancer Institute. He is an associate professor and master s supervisor at Wuhan University, and a deputy chief physician at Zhongnan Hospital of Wuhan University. He currently serves as the deputy director and director of Teaching for the Department of Rad
Inhalt
Part I. Introduction.- Chapter 1. Cancer Immunology and Immunotherapy.- Chapter 2. Basis of Radiobiology and Its Relevance to Immunoradiotherapy.- Chapter 3. Advanced Nanobiomaterials-mediated Radio-immunotherapy in Malignant Cancer.- Part II. The Immunoradiotherapy in Malignant Cancer.- Chapter 4. The Immunoradiotherapy in HNSCC.- Chapter 5. Progress of Radiotherapy Combined with Immunotherapy for Non-small Cell Lung Cancer.- Chapter 6. The Immunoradiotherapy in Nasopharyngeal Carcinoma.- Chapter 7. The Combination of Immunotherapy and Radiotherapy in Pancreatic Ductal Adenocarcinoma.- Chapter 8. The Immunoradiotherapy in Cervical Cancer.- Part III. The Future of Immunoradiotherapy.- Chapter 9. Pioneering Immunotherapy Agents and their Synergy with Radiotherapy.- Chapter 10. Dual Facets of Ionizing Radiation in Cancer Therapy: Immunomodulation and Immunosuppression.- Chapter 11. Precision Medicine in Immunoradiotherapy.
Weitere Informationen
- Allgemeine Informationen
- GTIN 09789819636587
- Editor Lin-Lin Bu, Bing Liu, Qiuji Wu
- Sprache Englisch
- Größe H241mm x B160mm x T22mm
- Jahr 2025
- EAN 9789819636587
- Format Fester Einband
- ISBN 978-981-9636-58-7
- Veröffentlichung 12.04.2025
- Titel The Fine Blueprint of Integrating Immunotherapy and Radiotherapy
- Untertitel From Molecular Mechanisms to Clinical Strategies
- Gewicht 709g
- Herausgeber Springer Nature Singapore
- Anzahl Seiten 324
- Lesemotiv Verstehen
- Genre Medical Books